@prefix dc1: .
@prefix this: .
@prefix sub: .
@prefix schema: .
@prefix np: .
@prefix rdf: .
@prefix nt: .
@prefix xsd: .
@prefix rdfs: .
@prefix orcid: .
@prefix bl: .
@prefix nkg: .
@prefix prov: .
@prefix npx: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo;
a np:Nanopublication .
}
sub:assertion {
bl:category bl:Disease .
sub:association rdf:object ;
rdf:predicate bl:treats;
rdf:subject ;
a rdf:Statement;
rdfs:label "Pitolisant and sodium oxybate show promising results in two retrospective studies. The efficacy of γ-aminobutyric acid-A receptor antagonists on objective EDS needs to be clarified. All these medications are used off-label for the management of EDS in IH.";
bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
bl:has_population_context sub:cohort;
bl:provided_by ;
bl:publications ;
bl:relation nkg:OffLabelIndication .
sub:cohort rdfs:label "Adults";
schema:requiredMinAge "Adults";
bl:category bl:Cohort;
bl:has_phenotype .
bl:category bl:Drug .
}
sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0002-7641-6446 .
}
sub:pubinfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB";
npx:hasSignature "PCn19b7Q4U1Dyn81tCVO0a/VlKqQ2oNUzmgtU/RD9aPVb7rAeS8kDzuH5eZnnGSsE1dsGpOMUPmZpkCJSaff6uuwcPWe5YdW7LVj8YGl0I1K0ASaUXxWUthNBgth6dSun4ZA1C65QEDXeRfCMXL+ANnDUPs/uQurgiYyyeTmfe8=";
npx:hasSignatureTarget this: .
this: dc1:created "2021-06-07T15:04:08.125+02:00"^^xsd:dateTime;
dc1:creator orcid:0000-0002-7641-6446;
nt:wasCreatedFromProvenanceTemplate ;
nt:wasCreatedFromPubinfoTemplate ;
nt:wasCreatedFromTemplate .
}